See where interventional psychiatry practices lose revenue, time, and capacity, and how to diagnose gaps in collections, A/R, billing, and operations.

Anita Clayton, MD, built the scale for measuring antidepressant sexual dysfunction. She made psychiatry pay attention to women's sexcual health, and was featured in the documentary "The Little Pink Pi...

Are GLP-1 agonists psychiatric drugs? The neuroscience of reward, new addiction trial data, and a dosing hypothesis that reframes anhedonia.

Hear how one Spravato patient went from cycling through 10 antidepressants to building a life he loves — running marathons, writing novels, and surfing. Ben Leopold shares how the combination of deep ...

Ready to add TMS to your practice? This guide covers patient eligibility, 2026 device pricing for 8 systems, financing, billing codes, and how to build your referral pipeline from day one.

CMS replaced S0013 with the new Spravato J code (J0013) in 2026, but payer rollouts have been inconsistent. Learn which prior authorizations need to be redone and how to protect your practice from cla...

Sleep apnea and depression are more connected than most clinicians realize—and standard testing often misses it. Dr. Avinesh Bhar breaks down the link and what psychiatrists can do about it.

A practical guide to building consistent referral volume for interventional psychiatry using systems, outreach strategy, and operations.

Vagal nerve stimulation (VNS) for depression improves progressively over 12-24 months with remarkably low relapse rates. Learn patient selection criteria, Medicare RECOVER trial access, insurance appe...